Produits laitiers et inflammation métabolique : quels liens en phase postprandiale et à long terme ?
Tài liệu tham khảo
Fumeron, 2011, Dairy products and the metabolic syndrome in a prospective study, DESIR, J Am Coll Nutr, 30, 454S, 10.1080/07315724.2011.10719990
Kai, 2014, Low-fat and high-fat dairy products are differently related to blood lipids and cardiovascular risk score, Eur J Prev Cardiol, 21, 1557, 10.1177/2047487313503283
Moore, 2008, Dairy intake and anthropometric measures of body fat among children and adolescents in NHANES, J Am Coll Nutr, 27, 702, 10.1080/07315724.2008.10719747
Hotamisligil, 2006, Inflammation and metabolic disorders, Nature, 444, 860, 10.1038/nature05485
Poitou, 2005, Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition, Diabetologia, 48, 519, 10.1007/s00125-004-1654-6
Yang, 2006, Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications, PLoS Med, 3, e287, 10.1371/journal.pmed.0030287
Alessi, 2000, Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity, Diabetes, 49, 1374, 10.2337/diabetes.49.8.1374
Shoelson, 2007, Obesity, inflammation, and insulin resistance, Gastroenterology, 132, 2169, 10.1053/j.gastro.2007.03.059
Trayhurn, 2004, Adipokines: inflammation and the pleiotropic role of white adipose tissue, Br J Nutr, 92, 347, 10.1079/BJN20041213
Cao, 2014, Adipocytokines in obesity and metabolic disease, J Endocrinol, 220, T47, 10.1530/JOE-13-0339
Kanda, 2006, MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity, J Clin Invest, 116, 1494, 10.1172/JCI26498
Inadera, 2008, The usefulness of circulating adipokine levels for the assessment of obesity-related health problems, Int J Med Sci, 5, 248, 10.7150/ijms.5.248
Botham, 2013, Postprandial lipoproteins and the molecular regulation of vascular homeostasis, Prog Lipid Res, 52, 446, 10.1016/j.plipres.2013.06.001
Fantuzzi, 2005, Adipose tissue, adipokines, and inflammation, J Allergy Clin Immunol, 115, 911, 10.1016/j.jaci.2005.02.023
Dalmas, 2011, Defining macrophage phenotype and function in adipose tissue, Trends Immunol, 32, 307, 10.1016/j.it.2011.04.008
Dandona, 1998, Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss, J Clin Endocrinol Metab, 83, 2907
Bastard, 1999, Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects, Circulation, 99, 2221, 10.1161/circ.99.16.2219/c
Bistrian, 2000, Chronic systemic inflammation in overweight and obese adults, JAMA, 283, 2235
Ghanim, 2004, Circulating mononuclear cells in the obese are in a proinflammatory state, Circulation, 110, 1564, 10.1161/01.CIR.0000142055.53122.FA
Vozarova, 2001, Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion, Obes Res, 9, 414, 10.1038/oby.2001.54
Kershaw, 2004, Adipose tissue as an endocrine organ, J Clin Endocrinol Metab, 89, 2548, 10.1210/jc.2004-0395
Fried, 1998, Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid, J Clin Endocrinol Metab, 83, 847
Fain, 2006, Most of the interleukin 1 receptor antagonist, cathepsin S, macrophage migration inhibitory factor, nerve growth factor, and interleukin 18 release by explants of human adipose tissue is by the non-fat cells, not by the adipocytes, Metabolism, 55, 1113, 10.1016/j.metabol.2006.04.008
Xu, 2003, Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance, J Clin Invest, 112, 1821, 10.1172/JCI200319451
Mohamed-Ali, 1997, Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo, J Clin Endocrinol Metab, 82, 4196
Hotamisligil, 1995, Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance, J Clin Invest, 95, 2409, 10.1172/JCI117936
Castell, 1990, Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6, Hepatology, 12, 1179, 10.1002/hep.1840120517
Visser, 1999, Elevated C-reactive protein levels in overweight and obese adults, JAMA, 282, 2131, 10.1001/jama.282.22.2131
Gutierrez, 2009, Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia, Curr Diab Rep, 9, 26, 10.1007/s11892-009-0006-9
Dali-Youcef, 2013, Metabolic inflammation: connecting obesity and insulin resistance, Ann Med, 45, 242, 10.3109/07853890.2012.705015
Ridker, 2003, C-reactive protein, inflammation, and coronary risk, Cardiol Clin, 21, 315, 10.1016/S0733-8651(03)00079-1
Blaha, 2011, Association between obesity, high-sensitivity C-reactive protein≥2mg/L, and subclinical atherosclerosis: implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis, Arterioscler Thromb Vasc Biol, 31, 1430, 10.1161/ATVBAHA.111.223768
Ridker, 2000, Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men, Circulation, 101, 1767, 10.1161/01.CIR.101.15.1767
Blackburn, 2006, Postprandial variations of plasma inflammatory markers in abdominally obese men, Obesity (Silver Spring), 14, 1747, 10.1038/oby.2006.201
Burdge, 2005, Plasma cytokine response during the postprandial period: a potential causal process in vascular disease?, Br J Nutr, 93, 3, 10.1079/BJN20041282
Aljada, 2004, Increase in intranuclear nuclear factor-kappa B and decrease in inhibitor kappa B in mononuclear cells after a mixed meal: evidence for a proinflammatory effect, Am J Clin Nutr, 79, 682, 10.1093/ajcn/79.4.682
Nappo, 2002, Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals, J Am Coll Cardiol, 39, 1145, 10.1016/S0735-1097(02)01741-2
Magne, 2010, Early postprandial low-grade inflammation after high-fat meal in healthy rats: possible involvement of visceral adipose tissue, J Nutr Biochem, 21, 550, 10.1016/j.jnutbio.2009.03.004
Alipour, 2007, Postprandial inflammation and endothelial dysfunction, Biochem Soc Trans, 35, 466, 10.1042/BST0350466
Poppitt, 2008, Postprandial response of adiponectin, interleukin-6, tumor necrosis factor-alpha, and C-reactive protein to a high-fat dietary load, Nutrition, 24, 322, 10.1016/j.nut.2007.12.012
Campbell, 2006, Effects of soy or milk protein during a high-fat feeding challenge on oxidative stress, inflammation, and lipids in healthy men, Lipids, 41, 257, 10.1007/s11745-006-5095-5
Herieka, 2014, High-fat meal induced postprandial inflammation, Mol Nutr Food Res, 58, 136, 10.1002/mnfr.201300104
Lundman, 2007, A high-fat meal is accompanied by increased plasma interleukin-6 concentrations, Nutr Metab Cardiovasc Dis, 17, 195, 10.1016/j.numecd.2005.11.009
Tholstrup, 2011, Dietary cocoa butter or refined olive oil does not alter postprandial hsCRP and IL-6 concentrations in healthy women, Lipids, 46, 365, 10.1007/s11745-011-3526-4
Teng, 2011, Palm olein and olive oil cause a higher increase in postprandial lipemia compared with lard but had no effect on plasma glucose, insulin and adipocytokines, Lipids, 46, 381, 10.1007/s11745-010-3516-y
Bellido, 2004, Butter and walnuts, but not olive oil, elicit postprandial activation of nuclear transcription factor-kappa B in peripheral blood mononuclear cells from healthy men, Am J Clin Nutr, 80, 1487, 10.1093/ajcn/80.6.1487
Peairs, 2011, Effects of acute ingestion of different fats on oxidative stress and inflammation in overweight and obese adults, Nutr J, 10, 122, 10.1186/1475-2891-10-122
Tsai, 2004, Effects of oxidative stress on endothelial function after a high-fat meal, Clin Sci (Lond), 106, 315, 10.1042/CS20030227
Erridge, 2007, A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation, Am J Clin Nutr, 86, 1286, 10.1093/ajcn/86.5.1286
Ghanim, 2009, Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance, Diabetes Care, 32, 2281, 10.2337/dc09-0979
Laugerette, 2011, Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation, J Nutr Biochem, 22, 53, 10.1016/j.jnutbio.2009.11.011
Laugerette, 2012, Oil composition of high-fat diet affects metabolic inflammation differently in connection with endotoxin receptors in mice, Am J Physiol Endocrinol Metab, 302, E374, 10.1152/ajpendo.00314.2011
Cani, 2008, Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice, Diabetes, 57, 1470, 10.2337/db07-1403
Neal, 2006, Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier, J Immunol, 176, 3070, 10.4049/jimmunol.176.5.3070
Ghoshal, 2009, Chylomicrons promote intestinal absorption of lipopolysaccharides, J Lipid Res, 50, 90, 10.1194/jlr.M800156-JLR200
Moreno-Navarrete, 2012, Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance, Int J Obes (Lond), 36, 1442, 10.1038/ijo.2011.256
Sun, 2010, A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese, Diabetes Care, 33, 1925, 10.2337/dc10-0340
Lamping, 1998, LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria, J Clin Invest, 101, 2065, 10.1172/JCI2338
Mathison, 1992, Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS, J Immunol, 149, 200, 10.4049/jimmunol.149.1.200
Tobias, 1992, Participation of lipopolysaccharide-binding protein in lipopolysaccharide-dependent macrophage activation, Am J Respir Cell Mol Biol, 7, 239, 10.1165/ajrcmb/7.3.239
Marshall, 2005, Lipopolysaccharide: an endotoxin or an exogenous hormone?, Clin Infect Dis, 41, S470, 10.1086/432000
Cani, 2007, Metabolic endotoxemia initiates obesity and insulin resistance, Diabetes, 56, 1761, 10.2337/db06-1491
Wurfel, 1994, Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS, J Exp Med, 180, 1025, 10.1084/jem.180.3.1025
Kelly, 2012, Of microbes and meals: the health consequences of dietary endotoxemia, Nutr Clin Pract, 27, 215, 10.1177/0884533611434934
Kemp, 2013, Does chronic low-grade endotoxemia define susceptibility of obese humans to insulin resistance via dietary effects on gut microbiota?, Adipocyte, 2, 188, 10.4161/adip.24776
de La Serre, 2010, Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation, Am J Physiol Gastrointest Liver Physiol, 299, G440, 10.1152/ajpgi.00098.2010
Cani, 2010, Impact du microbiote intestinal sur la perméabilité intestinale et les désordres métaboliques liés à l’obésité, Louvain Med, 129, S8
Le Chatelier, 2013, Richness of human gut microbiome correlates with metabolic markers, Nature, 29, 541, 10.1038/nature12506
Frazier, 2011, Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury, JPEN J Parenter Enteral Nutr, 35, 14S, 10.1177/0148607111413772
Creely, 2007, Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes, Am J Physiol Endocrinol Metab, 292, E740, 10.1152/ajpendo.00302.2006
Pastor Rojo, 2007, Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease, Inflamm Bowel Dis, 13, 269, 10.1002/ibd.20019
Gummesson, 2011, Intestinal permeability is associated with visceral adiposity in healthy women, Obesity (Silver Spring), 19, 2280, 10.1038/oby.2011.251
Amar, 2008, Energy intake is associated with endotoxemia in apparently healthy men, Am J Clin Nutr, 87, 1219, 10.1093/ajcn/87.5.1219
Lassenius, 2011, Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation, Diabetes Care, 34, 1809, 10.2337/dc10-2197
Zemel, 2008, Dietary calcium and dairy products modulate oxidative and inflammatory stress in mice and humans, J Nutr, 138, 1047, 10.1093/jn/138.6.1047
Panagiotakos, 2010, Dairy products consumption is associated with decreased levels of inflammatory markers related to cardiovascular disease in apparently healthy adults: the ATTICA study, J Am Coll Nutr, 29, 357, 10.1080/07315724.2010.10719852
Nestel, 2012, Circulating inflammatory and atherogenic biomarkers are not increased following single meals of dairy foods, Eur J Clin Nutr, 66, 25, 10.1038/ejcn.2011.134
Gagliardi, 2010, Effects of margarines and butter consumption on lipid profiles, inflammation markers and lipid transfer to HDL particles in free-living subjects with the metabolic syndrome, Eur J Clin Nutr, 64, 1141, 10.1038/ejcn.2010.122
Wang, 2011, Obesity modifies the relations between serum markers of dairy fats and inflammation and oxidative stress among adolescents, Obesity (Silver Spring), 19, 2404, 10.1038/oby.2011.234
Raff, 2008, A diet rich in conjugated linoleic acid and butter increases lipid peroxidation but does not affect atherosclerotic, inflammatory, or diabetic risk markers in healthy young men, J Nutr, 138, 509, 10.1093/jn/138.3.509
Zemel, 2010, Effects of dairy compared with soy on oxidative and inflammatory stress in overweight and obese subjects, Am J Clin Nutr, 91, 16, 10.3945/ajcn.2009.28468
Stancliffe, 2011, Dairy attentuates oxidative and inflammatory stress in metabolic syndrome, Am J Clin Nutr, 94, 422, 10.3945/ajcn.111.013342
Van Loan, 2011, Dairy foods in a moderate energy restricted diet do not enhance central fat, weight, and intra-abdominal adipose tissue losses nor reduce adipocyte size or inflammatory markers in overweight and obese adults: a controlled feeding study, J Obes, 2011, 989657, 10.1155/2011/989657
Masson, 2011, Exchanging saturated fatty acids for (n-6) polyunsaturated fatty acids in a mixed meal may decrease postprandial lipemia and markers of inflammation and endothelial activity in overweight men, J Nutr, 141, 816, 10.3945/jn.110.136432
Jimenez-Gomez, 2009, Olive oil and walnut breakfasts reduce the postprandial inflammatory response in mononuclear cells compared with a butter breakfast in healthy men, Atherosclerosis, 204, e70, 10.1016/j.atherosclerosis.2008.09.011
Manning, 2004, Changes in circulating postprandial proinflammatory cytokine concentrations in diet-controlled type 2 diabetes and the effect of ingested fat, Diabetes Care, 27, 2509, 10.2337/diacare.27.10.2509
Deopurkar, 2010, Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3, Diabetes Care, 33, 991, 10.2337/dc09-1630
Harte, 2012, High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects, Diabetes Care, 35, 375, 10.2337/dc11-1593
Ghanim, 2010, Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression, Am J Clin Nutr, 91, 940, 10.3945/ajcn.2009.28584
Clemente-Postigo, 2012, Endotoxin increase after fat overload is related to postprandial hypertriglyceridemia in morbidly obese patients, J Lipid Res, 53, 973, 10.1194/jlr.P020909
Fernandez-Real, 2011, CD14 modulates inflammation-driven insulin resistance, Diabetes, 60, 2179, 10.2337/db10-1210
Laugerette, 2014, Overfeeding increases postprandial endotoxemia in men: inflammatory outcome may depend on LPS transporters LBP and sCD14, Mol Nutr Food Res, 58, 1513, 10.1002/mnfr.201400044
Thompson, 2009, Measurement of postprandial interleukin-6 via a catheter: what does it tell us?, Eur J Appl Physiol, 107, 621, 10.1007/s00421-009-1171-x
Calder, 2013, A consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies, Br J Nutr, 109, S1, 10.1017/S0007114512005119
Ciapaite, 2007, Palmitate and oleate have distinct effects on the inflammatory phenotype of human endothelial cells, Biochim Biophys Acta, 1771, 147, 10.1016/j.bbalip.2006.12.005
Weigert, 2004, Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappa B, J Biol Chem, 279, 23942, 10.1074/jbc.M312692200
Ajuwon, 2005, Palmitate activates the NF-kappaB transcription factor and induces IL-6 and TNFalpha expression in 3T3-L1 adipocytes, J Nutr, 135, 1841, 10.1093/jn/135.8.1841